Skip to main content
Submitted by PatientsEngage on 16 June 2014

The function of the kidney is to rid the body of toxins and to purify the blood. Diabetes can reduce the kidney’s ability to filter waste products, leading to build-up of waste products in the body.

Anatomy of the kidney

This is how the kidney works: The end functioning unit of the kidney is the glomerulus, which filters out ammonia, urea and other chemicals from the blood entering the kidneys. Blood vessels that enter the kidney are called afferent and those exiting are called efferent. The afferent brings in the impure blood, which drains into pouch-like structure called the glomerulus where ammonia, urea etc is filtered out. The blood that is free of impurities exits through efferent blood vessels. 

The glomerulus’ power of filtration is called the Glomerulus Filtration Rate (GFR), a reading that indicates whether the blood is being filtered properly or not. If the glomerulus filters well, the blood is free of impurities. The optimal filtration rate should be between 90-120 ml/min/1.73m2 for at least 3 months. Any variation should be investigated. 

Diabetic nephropathy and its impact

Diabetes makes the kidneys filter too much blood, thus overworking them. Over time, the filtration system becomes inefficient. Waste products build up in the blood and the kidney leaks small amounts of protein into the urine. The presence of protein in urine is termed microalbuminuria, which is a bad sign. Without proper treatment to slow down the progression of the disease, the kidneys will fail and the patient may need to undergo kidney transplant. 

Approximately 20-30 per cent of Types 1 and 2 diabetics develop nephropathy or diseased kidney. The most common form is Chronic Kidney Disease (CKD), which is defined as the kidneys having Glomerular Filtration Rate (GFR) of < 60ml/min/1.73m2 for 3 or more months. 

Are you at risk

Increased blood sugar predisposes all diabetics to complications, including kidney damage.

Can nephropathy be prevented

Keeping blood sugar levels under control is the best preventive measure. Avoid smoking and drinking excessive amounts of alcohol. Regular exercise and a healthy, balanced diet is recommended. It is advisable to check kidney function every year.

Symptoms

 Most people with CKD have few or no symptoms. Some of the symptoms to look out for are:

• Swollen ankles, feet or hands (due to water retention) 

• Shortness of breath 

• Decrease in appetite and weight loss 

• Itchy skin

• Nausea 

• Blood or protein in your urine (protein is detected on a urine test) 

• Increased urination (particularly at night) 

• Muscle cramps

• High blood pressure (hypertension)

• Erectile dysfunction in men (an inability to get or maintain an erection)

What kind of screening tests should I have done

According to the International Diabetes Center, Type 1 diabetics should be screened at least 5 years after diagnosis of diabetes and annually thereafter. Type 2 diabetics should be screened on diagnosis and annually thereafter. Risk factors should be assessed and a testing of albumin to creatinine ratio - A/C ratio – is to be repeated annually. (A/C ratio of the first morning urine sample should be done at least on three consecutive days. If two of the readings show >30 mg/gm/24 hours, it signifies a diseased kidney.) 

Stages of nephropathy 

Here are the five stages of Chronic Kidney Disease (CKD) that are mainly based on measured or estimated Glomerular filtration rate (GFR) measured in ml/min/1.73m2. All GFR values are normalised to an average surface area (size) of 1.73m2

Stage 1: Renal Hypertrophy and glomerular hyperfiltration

Kidney damage* with normal or increased GFR >=90 

Hypertrophy refers to the enlargement of the kidney. Hyperfiltration is increased filtration due to increase in size of glomeruli or increased blood flow. This occurs with uncontrolled blood sugar and returns to normal with good blood sugar control. 

Stage 2: Apparent normalcy

Kidney damage* with mildly decreased GFR 60-89

This stage is clinically silent, which means that there are no clinical or laboratory signs of the disease. Symptoms such as urinary tract infections may show up after 5 to 15 years of a patient being diagnosed as a diabetic. Such symptoms can persist even when managed, hence frequent check-ups are required. In case of blood sugar of less than 250 mg/dl, there will be a reduction of GFR although not regularly seen at this stage. 

Stage 3: Microalbuminuria or incipient nephropathy

Moderately decreased GFR 30-59

This refers to an increase in albumin in the urine. This may occur in 20-30 per cent of diabetics after they have had the disease for 6-15 years. The ideal protein (albumin) in the urine is 30-300 mg/24 hours. 

Stage 4: Overt (or established) nephropathy

Severely decreased GFR 15-29

This is the classic stage showing kidney damage with its major characteristic being a persistent proteinuria, i.e. protein found in urine. If the amount of protein is more than 0.5grams per 24 hours, it indicates significant protein loss.

Stage 5: End-stage renal disease

Kidney failure; GFR < 15 or dialysis

Found in 25% of diabetic patients, both insulin-dependent and non insulin-dependent. Uremia (elevated blood urea nitrogen level) due to diabetes mellitus is the major problem seen in this stage.

*Kidney damage is defined as abnormalities on pathological, urine, blood or imaging tests.

Treatment 

As per the latest American Diabetes Association 2013 Guidelines, here are some of the options:

• If you are not pregnant, patients with modestly elevated (30-299 mg/day) or higher levels (>300 mg/day) of urinary albumin excretion, may be prescribed drugs like ACE (angiotensin converting enzyme) inhibitors or ARBs (angiotensin receptor blockers).

• Those with diabetes and the early stages of CKD are recommended reduced protein intake of 0.8–1.0 g/kg of body weight per day. Those in the later stages of CKD are advised to take 0.8g protein/kg of body weight per day. This may improve measures of renal function (urine albumin excretion rate, GFR). 

• When taking drugs such as ACE inhibitors, ARBs or diuretics, monitor serum creatinine and potassium levels for the development of increased creatinine or changes in potassium. 

• Reduce the dietary intake of salt to 5g per day to slow the progression of renal disease.

• Continued monitoring of urine albumin excretion to assess both response to therapy and progression of the disease. 

• When GFR is 60 mL/min/1.73 m2 or less, evaluate and manage potential complications of Chronic Kidney Disease. 

• Consider referral to a physician experienced in the care of kidney disease for uncertainty about the etiology of kidney disease, difficult management issues or advanced kidney disease.

Read more on Chronic Kidney Diseasehttp://www.patientsengage.com/condition/chronic-kidney-disease

Changed
Tue, 08/27/2019 - 04:39

Stories

  • Malays, Indians with Type 2 diabetes more likely to suffer strokes, heart attacks: Study
    SINGAPORE: In a decade-long diabetes study, researchers from Khoo Teck Puat Hospital (KTPH) found that among those with Type 2 Diabetes Mellitus (T2DM), Malays and Indians are at higher risk of cardiovascular diseases compared to Chinese patients. Malay patients had two times higher risk while Indians had 1.7 times higher risk of diseases such as heart attacks and strokes, compared to Chinese patients with T2DM, according to findings of a study released by the healthcare cluster that manages…
  • Diabetes has kept me healthy
    SR Madhu, 73, has had diabetes for 23 years, and has avoided the health hazards faced by his peers. He thanks the diabetes lifestyle for his wellbeing. Plus, his experience of hypoglycaemia.  I was quite upset to discover in 1991 that diabetes had hit me. I had been "on the borderline" of diabetes for a few years whenever I had been tested in India. But when I crossed the international border in 1991 to take up a UN assignment in Zimbabwe, the diabetes crossed…
  • FDA Approval For Two-In-One Diabetes Pill XIGDUO™ XR
    U.S. Food and Drug Administration has approved once-daily XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes. It is already approved in Australia XIGDUO XR combines two anti-hyperglycemic agents with complementary mechanisms of action, dapagliflozin (trade name in the U.S. FARXIGA™), an inhibitor of sodium-glucose cotransporter 2 (SGLT2), and metformin hydrochloride (HCl) extended-release, a biguanide, in a once-daily oral…
  • Giant leap in Type 1 Diabetes treatment
    Harvard stem cell researchers today announced that they have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a condition that affects an estimated 3 million Americans at a cost of about $15 billion annually. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing…
  • Diet for Chronic Kidney Disease patients
    Dietitian Ujjwala Baxi helps make sense of the diet guidelines and tells you what you can eat guilt-free. Good kidney function is essential for removing the waste material from food that we eat and other byproducts of the body. The kidneys excrete a dietary protein called urea, as well as sodium, potassium and phosphate. These substances can build up in the body if kidney function is impaired. If your kidneys are not working optimally, you need to follow a prescribed diet to lessen the…
  • Diabetes patient jabbing themselves with insulin
    Worried About Insulin Shots?
    Persons with diabetes often get extremely stressed when their doctor wants to move them from pills to insulin shots. Dr Shital Patel allays the fears and explains what to expect and how to go about it. The transition from pills to insulin injections can be a worrying experience for many Diabetes Type 2 patients. You should know that this does not mean that your diabetes has worsened or that your Type 2 diabetes has changed to Type 1. You are being prescribed insulin because after…
  • FDA approves Trulicity a weekly injectable to treat type 2 diabetes
    The U.S. FDA today approved Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. "Type 2 diabetes is a serious chronic condition that causes blood glucose levels to rise higher than normal,” said Mary Parks, M.D., deputy director of the Office of Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research. “Trulicity is a new treatment option, which can be used…
  • Artificial sweeteners may promote diabetes, claim scientists
    Artificial sweeteners may contribute to soaring levels of diabetes, according to a controversial study that suggests the additives could exacerbate the problem they are meant to tackle. Researchers in Israel found that artificial sweeteners used in diet drinks and other foods can disrupt healthy microbes that live in the gut, leading to higher blood sugar levels – an early sign of diabetes. But the study has left many experts unconvinced. The findings draw largely on tests of just one sweetener…
  • A woman holding up the pregnancy test kit
    Pre-conception care for a healthy pregnancy
    Planning a pregnancy? Obstetrician and gynaecologist Dr Chandan Dubey tells you what you need to do before you conceive. A woman’s good health prior to and during pregnancy is vital for optimal outcomes for her and the baby. You should consult a general physician or gynaecologist for preconception care and counselling. In the meantime, here’s what you should be aware of:  Lose weight (if you are overweight): Obesity is a serious problem in pregnancy. It increases the…
  • FDA approves weight-management drug Contrave
    The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obesity) or adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition such as high blood pressure (hypertension), type 2…